According to MarketsandMarkets™, The global Respiratory care devices market is projected to reach USD 33.6 billion by 2030 from USD 23.6 billion in 2025, at a CAGR of 7.3%.
Browse 587 market data Tables and 63 Figures spread through 466 Pages and in-depth TOC on “Respiratory Care Devices Market”.
Respiratory Care Devices Market Size & Forecast:
- Market Size Available for Years: 2025–2030
- 2025 Market Size: 23.6 billion
- 2030 Projected Market Size: 33.6 billion
- CAGR (2025–2030): 7.3 %
Respiratory Care Devices Market Trends & Insights:
1. The respiratory care devices market is witnessing robust growth, driven by the rising prevalence of chronic respiratory diseases like COPD, asthma, and sleep apnea, increasing air pollution, and aging populations globally.
2. The respiratory care devices market is being increasingly driven by disease indications such as COPD, asthma, and sleep apnea.
3. The demand for respiratory care equipment is largely influenced by hospitals.
4. Asia Pacific is projected to grow fastest with a CAGR of 8.0%
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=368
Market Dynamics and Growth Drivers:
The respiratory care devices market is being propelled by a blend of demographic, medical, and environmental factors. Who is driving demand? An aging global population, patients with long-term smoking histories, and individuals exposed to rising levels of air pollution are contributing to higher incidences of asthma, sleep apnea, and chronic obstructive pulmonary disease (COPD).
How has the COVID-19 pandemic reshaped the market landscape? The global surge in ventilator procurement, oxygen therapy equipment, and patient monitoring systems significantly elevated awareness and investment in respiratory support infrastructure. This shift not only addressed immediate pandemic needs but also created long-term capital allocation toward respiratory preparedness and critical care capacity.
Furthermore, what is changing in care delivery models? There is growing demand for portable, homecare-based respiratory equipment that enables treatment beyond hospital settings. Cloud-connected devices, wireless monitoring systems, and smart inhalers are expanding access while supporting remote patient management. This evolution toward decentralized, technology-enabled respiratory care is redefining competitive dynamics across the industry.
Product Segment Insights:
By product type, the therapeutic devices segment is expected to account for the largest market share during the forecast period. Why do therapeutic devices dominate? These solutions are essential for managing both acute and chronic respiratory conditions, providing life-sustaining therapy to patients with COPD, asthma, sleep apnea, and respiratory failure.
Therapeutic devices such as high-flow nasal cannula systems, CPAP and BiPAP devices, nebulizers, ventilators, and oxygen concentrators remain indispensable in both hospital and homecare settings. The increasing need for long-term respiratory therapy, combined with rising hospitalization rates and the global burden of chronic disease, has significantly expanded this segment’s footprint.
For healthcare executives, this indicates sustained revenue streams anchored in recurring usage and long-term patient dependency.
Disease Indication Analysis:
By disease indication, COPD is expected to account for the largest share of the respiratory care devices market through 2030. What explains COPD’s dominant position? As a progressive and irreversible condition, COPD requires continuous monitoring and long-term respiratory therapy, often involving non-invasive ventilators, oxygen concentrators, nebulizers, and monitoring equipment.
Why is COPD becoming more prevalent globally? Key risk factors—including smoking, air pollution, occupational exposure, and aging—remain widespread in both developed and emerging markets. Frequent hospitalizations and exacerbations further increase the need for consistent respiratory equipment use across care settings.
For policymakers and healthcare providers, this underscores the urgency of investing in scalable respiratory care infrastructure and preventive interventions.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=368
Regional Outlook:
In 2024, North America accounted for the largest share of the global respiratory care devices market. What positions the region as a market leader? A high prevalence of asthma, COPD, and sleep apnea—driven by aging demographics, obesity trends, and smoking history—continues to sustain demand.
The region benefits from advanced healthcare infrastructure, strong reimbursement frameworks, and high awareness of respiratory health. Additionally, the pandemic catalyzed long-term investments in oxygen therapy equipment and ventilators, reinforcing institutional preparedness. Rapid adoption of remote monitoring solutions and telehealth integration further strengthens North America’s competitive advantage.
Meanwhile, emerging markets are expected to experience accelerated growth as healthcare access improves and air quality concerns intensify.
Competitive Landscape:
Key players shaping the global respiratory care devices market include Koninklijke Philips N.V., Medtronic, ResMed Inc., Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, GE HealthCare, Masimo, Getinge, Nihon Kohden Corporation, Air Liquide, ICU Medical, Inc., Hamilton Medical, Medline Industries, LP, Drive DeVilbiss Healthcare, and OMRON Healthcare, Inc, among others.
These organizations are investing heavily in innovation, connected respiratory ecosystems, and homecare expansion strategies to capture emerging demand and strengthen global distribution networks.
Why This Matters Now:
For C-suite executives, the respiratory care devices market represents a high-growth, mission-critical segment within the broader medical devices industry. As chronic respiratory conditions rise and healthcare models shift toward remote and home-based care, strategic investment in therapeutic respiratory solutions, digital integration, and scalable infrastructure is no longer optional—it is imperative.
Related Reports:
Respiratory Diagnostics Market– Global Forecast to 2030
Top 10 Medical Device Technologies Market – Global Forecast to 2027
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html